美东时间2020年5月15日,ZNTL股价今开38.1800美元,盘中最高42.8300美元,盘中最低35.8100美元,股价收跌5.51%,跌2.0900点,报35.8700美元

ZNTL简介

Zentalis Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It use its highly efficient drug discovery engine, which it refer to as its Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believe could result in potentially differentiated product profiles. Its discovery engine combines its extensive experience and capabilities across cancer biology and medicinal chemistry.